Gene · 3326
Papers4,343
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,343
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Uncovering the Anti-Atherosclerotic Effect of Isoquercitrin via Microbiome Metabolic Modulation and Network Pharmacology. | J Agric Food Chem | 2025 | 40916588 | PubTator, text mining | PubMed |
| Molecular mechanisms of mitochondrial quality control. | Transl Neurodegener | 2025 | 40887660 | PubTator, text mining | PubMed |
| ARRDC4-mediated glycolysis enhances innate immunity to influenza A virus through fructose-1,6-bisphosphate. | Proc Natl Acad Sci U S A | 2025 | 40875808 | PubTator, text mining | PubMed |
| Exploring Regulatory Frameworks for Exosome Therapy: Insights and Perspectives. | Health Care Sci | 2025 | 40861511 | PubTator, text mining | PubMed |
| The role of Ephexin1 in translation and mTOR-targeted cancer therapy. | Exp Mol Med | 2025 | 40855114 | PubTator, text mining | PubMed |
| Single-cell RNA transcriptome analysis reveals regulatory programs of RNA binding proteins in diabetic foot ulcers. | Sci Rep | 2025 | 40849582 | PubTator, text mining | PubMed |
| Analyzing the mechanism of rhubarb in the treatment of cervical cancer based on network pharmacology and molecular docking technology. | Sci Rep | 2025 | 40819186 | PubTator, text mining | PubMed |
| Protein modifications by advanced glycation end products (AGEs) in human clear cell renal cell carcinoma. | J Transl Med | 2025 | 40813989 | PubTator, text mining | PubMed |
| Phosphoproteomic insights into GFPT2-Associated cellular phospho-signaling networks. | Biochem Biophys Rep | 2025 | 40808719 | PubTator, text mining | PubMed |
| Investigating the Components Change of Steamed Corydalis yanhusuo via Mass Spectrometry Imaging, HS-GC-IMS, HPLC, and Network Pharmacology to Unveil Mechanism for Antichronic Atrophic Gastritis. | Biomed Chromatogr | 2025 | 40792414 | PubTator, text mining | PubMed |
| CD36 attenuates pressure overload-induced myocardial insulin resistance via HSF1-dependent HSP90α suppression and competitive disruption of the HSP90α-InsR complex. | J Transl Med | 2025 | 40770340 | PubTator, text mining | PubMed |
| Elevated plasma HSP90α as a prognostic marker in EGFR-mutant non-small cell lung cancer. | Oncol Lett | 2025 | 40762018 | PubTator, text mining | PubMed |
| Co-occurrence of clonally related follicular lymphoma and histiocytic sarcoma. | Blood Cancer J | 2025 | 40759639 | PubTator, text mining | PubMed |
| Chemerin-stimulated HSP90AB1 SUMOylation promotes monocyte activation and ERK1/2 phosphorylation via β2 integrin. | Cell Signal | 2025 | 40744335 | PubTator, text mining | PubMed |
| Revealing the impact of Pseudomonas aeruginosa quorum sensing molecule 2'-aminoacetophenone on the human bronchial-airway epithelium and pulmonary endothelium using a human airway-on-a-chip. | Front Immunol | 2025 | 40735328 | PubTator, text mining | PubMed |
| Hsp90 pan and Isoform-Selective Inhibitors as Sensitizers for Cancer Immunotherapy. | Pharmaceuticals (Basel) | 2025 | 40732313 | PubTator, text mining | PubMed |
| The Interaction of DMRTA2 with HSP90β Inhibits p53 Ubiquitination and Activates the p53 Pathway to Suppress the Malignant Progression of Non-Small-Cell Lung Cancer. | Curr Issues Mol Biol | 2025 | 40728966 | PubTator, text mining | PubMed |
| Proteomic Analysis of Hsp90β-Selective Inhibitors Against Triple-Negative Breast Cancer to Gain a Mechanistic Insight. | Mol Cell Proteomics | 2025 | 40714319 | PubTator, text mining | PubMed |
| Editorial: Molecular chaperones and polyamines in disease. | Front Mol Biosci | 2025 | 40703707 | PubTator, text mining | PubMed |
| Identification and modulation of a PI3K/AKT/mTOR pathway-targeting microRNA in order to increase colorectal cancer cells radiosensitivity in vitro. | BMC Cancer | 2025 | 40660203 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3326/papers?page=8